Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Head and Neck Neoplasms × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 22 pembrolizumab 20 Radiotherapy 19 Cetuximab 16 Radiotherapy, Intensity-Modulated 10 Fluorouracil 10 Docetaxel 9 Paclitaxel 8 Radiation 7 Nivolumab 6 Everolimus 6 Carboplatin 6 Gemcitabine 5 Surgical Procedures, Operative 4 Amifostine 4 Radiosurgery 3 Pemetrexed 3 Oxaliplatin 3 Magnetic Resonance Spectroscopy 3 Gefitinib 3 Filgrastim 3 Biopsy 3 spartalizumab 2 pegfilgrastim 2 niraparib 2 bempegaldesleukin 2 atezolizumab 2 advexin 2 X-Rays 2 VTX-2337 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01126216 2021-05-04

Paccis-RCT

University of Erlangen-Nürnberg Medical School

Phase 3 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡